Articles by Disease (Lymphoma)

Persistent Clinical Response of Infliximab Therapy in Patients with Refractory Rheumatoid Arthritis, over a 3-Year Period

Journal: Current Clinical Pharmacology
Volume: 1
Page: 103-108
Author(s): Paraskevi V. Voulgari, Yannis Alamanos and Alexandros A. Drosos

Kidney Diseases and Chemokines

Journal: Current Drug Targets
Volume: 7
Page: 65-80
Author(s): Ulf Panzer, Oliver M. Steinmetz, Rolf A.K. Stahl and Gunter Wolf

Lymphoproliferative Disorders and Chemokines

Journal: Current Drug Targets
Volume: 7
Page: 81-90
Author(s): V. Pistoia, A. Corcione, F. Dallegri and L. Ottonello

Clinical Pharmacology of Cyclophosphamide and Ifosfamide

Journal: Current Drug Therapy
Volume: 1
Page: 55-84
Author(s): Jing Zhang, Quan Tian and Shu-Feng Zhou

Fluoroquinolones in Pediatrics

Journal: Current Drug Therapy
Volume: 1
Page: 117-125
Author(s): Adriano Arguedas, Hernan Sierra and Carolina Soley

Treatment of Acute Leukaemias with Monoclonal Antibodies: Current Status and Future Prospects

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 4
Page: 33-52
Author(s): G. Leone, S. Sica, M. T. Voso, S. Rutella and L. Pagano

Novel Agents Aiming at Specific Molecular Targets Increase Chemosensitivity and Overcome Chemoresistance in Hematopoietic Malignancies

Journal: Current Pharmaceutical Design
Volume: 12
Page: 111-128
Author(s): Simone Boehrer, Daniel Nowak, Dieter Hoelzer, Paris S. Mitrou and Kai U. Chow